We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Colonoscopy Reduces Colorectal Cancer Risk, But Only on the Left Side

By HospiMedica International staff writers
Posted on 12 Jan 2010
A new study of colonoscopy screening in the community setting shows that it does reduce the risk for colorectal cancer, but only for left-sided, not right-sided, cancers.

Researchers at the German Cancer Research Center (DKFZ; Heidelberg) and other institutions conducted a cross-sectional study involving 3,287 participants from the German state of Saarland aged 55 years or older who underwent screening colonoscopy between May 1, 2005, and December 31, 2007. More...
Prevalence of advanced colorectal neoplasms was ascertained by screening colonoscopy and histopathologic examination of any polyps excised. Previous colonoscopy history was obtained by standardized questionnaire, and its association with prevalence of advanced colorectal neoplasms was estimated after adjustment for potential confounding factors.

The results showed that advanced colorectal neoplasms were detected in 308 (11.4%) of the 2,701 participants with no previous colonoscopy, compared with 36 (6.1%) of the 586 participants who had undergone colonoscopy within the preceding 10 years. After adjustment, the results showed that the prevalence ratios for previous colonoscopy in the previous 10-year period were 0.52 overall; 0.99 in the cecum and ascending colon; 1.21 in the hepatic flexure and transverse colon; and 1.05 in the combined right-sided colon (cecum to transverse colon). In the splenic flexure and descending colon, the prevalence ratio was 0.36; 0.29 in the sigmoid colon; 0.07 in the rectum; and 0.33 in the combined left colon (splenic flexure to rectum). The researchers concluded that the prevalence of left-sided advanced colorectal neoplasms, but not right-sided advanced neoplasms, was strongly reduced within a 10-year period after colonoscopy, even in the community setting. The study was published online on December 30, 2009, in the Journal of the National Cancer Institute.

"Although a strong protective effect of colonoscopy from colorectal neoplasms has been established through previous studies, our results add to the evidence that this effect is much stronger in, if not confined to, the left colon and rectum--at least in the community setting,” said lead author Hermann Brenner, M.D, M.P.H, of the DKFZ.

Colonoscopy is the endoscopic examination of the colon and the distal part of the small bowel with a video or fiberoptic camera on a flexible tube passed through the anus. It may provide a visual diagnosis of ulceration and polyps, and grants the opportunity for biopsy and removal of suspected lesions.

Related Links:

German Cancer Research Center



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.